Dishman Pharmaceuticals to issue NCDs worth Rs 75 crore

| January 14, 2010 | 1 Comment

Dishman Pharmaceuticals and Chemicals’ board has approved the proposal to issue non-convertible debentures (NCDs) up to an amount of Rs 75 crore, for augmenting medium to long-term resources of the company, including regular capital expenditure.

Dishman Pharmaceuticals is engaged in manufacturing of Bulk APIs, Intermediates, Specialties and Quats.

Popularity: 1% [?]

Tags: ,

Category: Company Annoucements